An2 Therapeutics, Inc. · NASDAQ:ANTX

Brii Biosciences Limited's stake in An2 Therapeutics, Inc. fell to 3.10% (Schedule 13G/A)

Event Dec 31, 2024 · Filed Feb 14, 2025

Brii Biosciences Limited's stake in An2 Therapeutics, Inc. fell to 3.10%, 927,201 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).

Stake
3.10%
Shares
927,201
Intent
Passive
What changed
Fell below 5%

The filing in full

HolderStakeShares
Brii Biosciences Limited3.10%927,201

Source

View original at SEC

Related